Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 2003

View Archived Issues

Stampidine demonstrates potent antiretroviral activity in chronically FIV-infected cats

Novel MMP and/or TNF-alpha production inhibitors under study at Fujisawa

Researchers at Akzo Nobel identify new metabolically stable androgenic agents

New Tie-2 and/or VEGFR2 kinase inhibitors prepared and tested by GSK scientists

Novel benzazepine-based CCR5 antagonists and their use in HIV infection

Several series of B-Raf kinase inhibitors discovered at GSK

Novel NK1 antagonists with utility in pain, depression, anxiety, etc.

Schering-Plough and Novartis to codevelop Asmanax/Foradil combination product

Novel CXCR4 receptor antagonist with potent and selective anti-HIV-1 activity

Glatiramer acetate slows neurological disability progression in MS

New data on the effects of SLV-306 and its potential use in congestive heart failure

Ghrelin reported to promote sleep in humans

Efficacy of parecoxib in postoperative pain following orthopedic surgery

E-5564 effective in septic shock

Good efficacy and safety profile for ziprasidone in acute bipolar mania

TA-CD enters phase IIa cocaine administration study

BresaGen demonstrates functional proof of concept for cell therapy in PD

Rebetol granted priority review for pediatric hepatitis C

Axokine promotes weight loss in phase II study

ENT-103 reviewed by expert pain panel

EG-3306 inhibits retinal neovascularization in vitro

Ribozyme concludes Medizyme joint venture with Elan

Scientists have mapped the genetic sequence of the virus believed to cause SARS

Idenix reports positive results for NM-283 and telbivudine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...